DENVER–(BUSINESS WIRE)–Lumen Technologies, Inc. (“Lumen,” “us,” “we,” or “our”) (NYSE: LUMN) today announced that its Board of Directors has approved the voluntary transfer of the listing of Lumen’s common stock, as well as the 6.500% Notes due 2051 (CTGG) and 6.750% Notes due 2052 (CTHH) issued by its wholly owned subsidiary, Qwest Corporation (the “Securities”), from the New York Stock Exchange (“NYSE”) to The Nasdaq Stock Market LLC (“Nasdaq”). Lumen and Qwest Corporation have filed applic
Author: sHq_LoGiNz
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will present new data from its portfolio of treatments for Duchenne muscular dystrophy at the 31st Annual Congress of the World Muscle Society (WMS), taking place Sept. 29 – Oct. 3, in Hiroshima, Japan. Data at WMS includes a late-breaking poster presentation on delandistrogene moxeparvovec efficacy and safety in older, ambulatory Duchenne patients in Sarepta’
OLDWICK, N.J.–(BUSINESS WIRE)–AM Best will sponsor and exhibit at the Association of Insurance Compliance Professionals (AICP) Annual Conference at the Louisville Marriott Downtown in Kentucky, Oct. 10–13, 2026. Join Director of Product Strategy Scott Jordan and Managers John Czuba and Matt Radman to learn more about the resources AM Best offers to insurance professionals, including:Best’s State Rate Filings®: Keep up with U.S. property/casualty and life/health program innovations, find out wh
COLUMBUS, Ohio–(BUSINESS WIRE)–McGraw Hill, Inc. (the “Company”) announced today that McGraw-Hill Education, Inc., the Company’s wholly-owned subsidiary (the “Issuer”) intends, subject to market conditions, to offer $500 million in aggregate principal amount of senior secured notes due 2033 (the “Notes”) in a private offering (the “Offering”). The Notes will be guaranteed by the Issuer’s parent, Mav Intermediate Holding II Corporation, and certain of the Issuer’s direct and indirect subsidiar
LONDON–(BUSINESS WIRE)– FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be
LONDON–(BUSINESS WIRE)– FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be
LONDON–(BUSINESS WIRE)– FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be
LONDON–(BUSINESS WIRE)– FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be
Originally published on CVS Health Company Newsroom
The demand for reliable energy continues to grow, and for CVS Health, dependable operations are essential to serving millions of patients and customers across the country. That’s why we’re expanding our use of renewable electricity and investing in energy solutions that help reduce emissions, strengthen business resilience and support uninterrupted care. These efforts are part of our goal to source 50% of our energy from renewable electricity by 2040 while building a healthier, more sustainable future for the communities we serve.
Through new and expanded power purchase agreements (PPAs), we’re increasing our use of clean electricity to support our operations. These efforts are part of our broader approach to sustainability, one that’s rooted in improving health outcomes over time.
“As a health solutions company, we recognize that the health of our communities is closely connected to the health of our environment,” said Jenny McColloch, Chief Sustainability Officer of CVS Health. “By investing in renewable energy, we’re reducing emissions, strengthening the resilience of our operations and ensuring continuity of care for the patients and customers we serve in communities across the country.”
Why renewable energy agreements matter
The need for reliable, affordable energy is growing, especially as industries expand and power demand increases. Across sectors, organizations are turning to renewable energy sources to strengthen long-term energy stability and manage costs.
For CVS Health, renewable energy agreements help support the stores, pharmacies, clinics and facilities that patients and customers rely on every day. They also help strengthen the energy system and support a cleaner future for the communities we serve.
What’s happening
Since 2022, we’ve made seven large-scale investments in renewable energy. Most recently in Maryland and putting energy-saving solutions into practice across our operations to reduce energy use and improve efficiency.
So far, we’ve secured agreements to source more than 969,000 megawatt hours (MWh) of clean energy as these projects come online. These efforts are helping move us closer to our goal of sourcing 50% renewable electricity by 2040. In 2025, renewable electricity represented approximately 33% of our total electricity use.
How a renewable energy power purchase agreement works
A power purchase agreement is a long-term contract that supports the development of renewable energy projects, such as solar and wind farms, while allowing CVS Health to purchase renewable electricity without building or operating the projects ourselves.
Here’s how it works in practice:
- Renewable energy is generated offsite from projects across the U.S.
- That energy is delivered to the grid and helps increase the overall supply of clean electricity
- CVS Health receives the environmental benefits, which are credited against our electricity use
These agreements typically span multiple years, providing predictable access to clean energy sources while supporting the development of new renewable capacity.
What clean energy means for CVS Health’s carbon footprint
Our renewable energy investments are a key part of reducing our Scope 2 GHG emissions – the emissions associated with the electricity we use to operate our stores, clinics and facilities.
By increasing the amount of clean electricity in our energy mix, we’re making steady progress toward lowering our overall carbon footprint.
These efforts help us:
- Improve the efficiency of how we operate
- Support long-term energy reliability
- Contribute to a more sustainable energy system
All of which ultimately support the communities and patients we serve. They also help improve air quality by reducing reliance on fossil fuels, which can contribute to respiratory and cardiovascular health issues. At the same time, investing in a more resilient energy system helps us continue serving patients and communities during periods of increased demand and extreme weather.
The bottom line
Investing in renewable energy is one way we’re helping build a healthier future. By reducing emissions, supporting cleaner air and strengthening the resilience of our operations, we’re helping ensure we can continue caring for patients and serving communities today and in the years ahead.
ATLANTA–(BUSINESS WIRE)–QumulusAI (Nasdaq: QMLS), a neocloud infrastructure provider purpose-built for the AI computing era, today announced the release of a new Futurum Research report, sponsored by QumulusAI, which finds that agentic AI can increase token consumption per task by 10 to 100 times compared with a simple inference call. That increase can expose organizations using per-token services to unpredictable and rising costs as applications move into production and scale across the enter